Graduate Institute of Epidemiology, National Taiwan University, Taipei, Taiwan.
J Med Virol. 2013 Sep;85(9):1567-76. doi: 10.1002/jmv.23651.
The associations between variants of human papillomavirus (HPV) 16 and risk of cervical neoplasia have been reported, but nucleotide variations of HPV 16 in Asian populations and their association with cervical neoplasia have not been evaluated extensively. During 1991-1992, 11,923 women from seven townships in Taiwan were enrolled. The HPV DNA in cervical cells was detected and genotyped using EasyChip HPV blot. Nucleotide variations in the long control region (LCR), E6, and E7 genes were determined using DNA sequencing for 170 HPV 16-positive cervical samples. The Asian variant was the most prevalent variant (81.8%) of HPV 16 in Taiwan, and was also associated with increased prevalence of histologically confirmed cervical intraepithelial neoplasia grade 3 or worse, showing an age-adjusted odds ratio (exact confidence limits) of 10.70 (1.62-451.05; P = 0.0049) compared to the HPV 16 European variant. Similar significant associations with cervical intraepithelial neoplasia grade 3 or worse were also observed for distinct nucleotide substitutions, including T178A/G, A647G, A7730C/G, T7781C, G7842A, and C24T/G. These results demonstrate that non-European variants (non-E) of HPV 16, predominantly Asian variants, are associated with increased risk for severe cervical neoplasia, compared with European variants. Molecular mechanisms accounting for varied cervical neoplasia risk among different HPV 16 variants warrant further investigation.
已报道了人乳头瘤病毒(HPV)16 变体与宫颈癌风险之间的关联,但亚洲人群中 HPV 16 的核苷酸变异及其与宫颈癌的关联尚未得到广泛评估。1991-1992 年,台湾七个乡镇的 11923 名女性入组。使用 EasyChip HPV blot 检测宫颈细胞中的 HPV DNA 并进行基因分型。对于 170 例 HPV 16 阳性的宫颈样本,使用 DNA 测序确定长控制区(LCR)、E6 和 E7 基因中的核苷酸变异。亚洲变体是台湾 HPV 16 最常见的变体(81.8%),与组织学证实的宫颈上皮内瘤变 3 级或更高级别患病率增加相关,与 HPV 16 欧洲变体相比,其年龄调整优势比(确切置信区间)为 10.70(1.62-451.05;P=0.0049)。对于包括 T178A/G、A647G、A7730C/G、T7781C、G7842A 和 C24T/G 在内的不同核苷酸取代,也观察到与宫颈上皮内瘤变 3 级或更高级别相似的显著关联。这些结果表明,与欧洲变体相比,非欧洲变体(非-E)HPV 16,主要是亚洲变体,与严重宫颈癌风险增加相关。不同 HPV 16 变体导致宫颈癌风险差异的分子机制值得进一步研究。